
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/"  version="2.0">

<channel>
	<title>Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<description>Oncology News, Cancer Research &#38; Clinical Insights</description>
	<lastBuildDate>Thu, 11 Jun 2026 06:17:16 +0000</lastBuildDate>
	<language>en-US</language>
	<ttl>10</ttl>
	<copyright><![CDATA[P53 Inc.]]></copyright>
	<generator>Oncodaily.com</generator>
	<image>
		<url>https://oncodaily.com/pub/themes/oncodailynews/img/logo-ODN-round.png</url>
		<title>OncoDaily News</title>
		<link>https://oncodaily.com</link>
	</image>

	
<image>
	<url>https://oncodaily.com/pub/uploads/2025/10/OD-favicon-blank-320x320.webp</url>
	<title>Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>10 Must-Read Posts In GI Oncology This Week</title>
		<link>https://oncodaily.com/oncolibrary/gastrointestinal-oncology/gi-oncology-3</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/10-gi-1280x720.webp" />
		<pubDate>Thu, 11 Jun 2026 06:17:16 +0000</pubDate>
		<guid isPermaLink="false">1a1f570918f25b3542a50cd5ea820bb0</guid>
				<category><![CDATA[Gastrointestinal Oncology]]></category>
		<category><![CDATA[Biliary tract cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer care]]></category>
		<category><![CDATA[Cancer research]]></category>
		<category><![CDATA[cancer treatment]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[colorectal cancer]]></category>
		<category><![CDATA[gastric cancer]]></category>
		<category><![CDATA[GI oncology]]></category>
		<category><![CDATA[Hepatocellular carcinoma (HCC)]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/10-gi-1280x720.webp"/> <br/> <br/> The last days of May and the first week of June brought together several important discussions in GI oncology, with expert posts highlighting new research, surgical innovation, precision oncology, screening, [&#8230;]]]></description>
							</item>
		<item>
		<title>Jordan Abbott: Physician Burnout Is a Systems Problem Not a Medicine Problem</title>
		<link>https://oncodaily.com/voices/jordan-abbott518790</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/05/q1sx-1.webp" />
		<pubDate>Thu, 11 Jun 2026 05:10:05 +0000</pubDate>
		<guid isPermaLink="false">fa330045b3983cf30fc936c648648a2b</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Jordan Abbott]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Physician Burnout]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/05/q1sx-1.webp"/> <br/> <br/> Jordan Abbott, Dermatologist, Co-founder of Physicians Invest, shared a post on X: &#8220;Physicians are not burned out because medicine is hard. Medicine has always been hard. That is not new. We [&#8230;]]]></description>
							</item>
		<item>
		<title>Immunotherapy in Head and Neck Cancer</title>
		<link>https://oncodaily.com/oncolibrary/immune-oncology/head-and-neck-io</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/IMAGE-2026-06-10-164533.webp" />
		<pubDate>Thu, 11 Jun 2026 04:18:07 +0000</pubDate>
		<guid isPermaLink="false">8d6301ff329cb239cf1bce8972a249cd</guid>
				<category><![CDATA[Immune Oncology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[HNSCC]]></category>
		<category><![CDATA[HNSCC immunotherapy]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[OncoDaily IO]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/IMAGE-2026-06-10-164533.webp"/> <br/> <br/> The addition of immunotherapy has been a major leap forward in managing squamous cell carcinoma of the head and neck. Currently, immunotherapy is a viable option for metastatic and recurrent [&#8230;]]]></description>
							</item>
		<item>
		<title>Laura Esserman Celebrates Kirithiga Ramalingam’s UCSF Surgery Graduation</title>
		<link>https://oncodaily.com/voices/laura-esserman518777</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/85a00b8f75a14bbeadc1799c1ee3056c.webp" />
		<pubDate>Thu, 11 Jun 2026 03:59:34 +0000</pubDate>
		<guid isPermaLink="false">51f4789a9ddeb81c5038d1df3b64f7f3</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Kirithiga Ramalingam]]></category>
		<category><![CDATA[MD Anderson Cancer Center]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[personalized medicine]]></category>
		<category><![CDATA[UCSF Department of Surgery]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/85a00b8f75a14bbeadc1799c1ee3056c.webp"/> <br/> <br/> Laura Esserman, Principal Investigator at The WISDOM Study, shared a post on LinkedIn: &#8220;Congratulations to Kirithiga Ramalingam on her graduation from UCSF Department of Surgery residency &#8211; another huge milestone in her quest [&#8230;]]]></description>
							</item>
		<item>
		<title>Joshua Richter: Noopur Raje is Simply a World Class Myeloma Doctor &#8211; Such a Well Deserved Award</title>
		<link>https://oncodaily.com/voices/joshua-richter-518750</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/BeFunky-MY-Collages7-1280x720.webp" />
		<pubDate>Thu, 11 Jun 2026 03:36:06 +0000</pubDate>
		<guid isPermaLink="false">8db7c14058dbb2e3ab7fbb3a2357f319</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Joshua Richter]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/BeFunky-MY-Collages7-1280x720.webp"/> <br/> <br/> Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology Center of Excellence for Multiple Myeloma at The Tisch Cancer Institute, shared a post on X: &#8220;Noopur Raje is simply a [&#8230;]]]></description>
							</item>
		<item>
		<title>Dimitrios Doultsinos: Had the Privilege of Presenting My Work at EACR2026 in Budapest Yesterday!</title>
		<link>https://oncodaily.com/voices/dimitrios-doultsinos-518742</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/95bc8667a2094e3ca6785281c0f791c2.webp" />
		<pubDate>Thu, 11 Jun 2026 03:32:19 +0000</pubDate>
		<guid isPermaLink="false">27729aa0f954b27cc75f90d2dbbd19ad</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Arkaitz Carracedo]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cris Cancer Foundation]]></category>
		<category><![CDATA[Dimitrios Doultsinos]]></category>
		<category><![CDATA[EACR]]></category>
		<category><![CDATA[EACR 2026]]></category>
		<category><![CDATA[EACR2026]]></category>
		<category><![CDATA[EACR26]]></category>
		<category><![CDATA[Ellie MacLeod]]></category>
		<category><![CDATA[Ian Mills]]></category>
		<category><![CDATA[Imogen Bridges]]></category>
		<category><![CDATA[Nuffield Department of Surgical Sciences - University of Oxford]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Prostate Cancer Foundation]]></category>
		<category><![CDATA[Sophia Abusamra]]></category>
		<category><![CDATA[Tanya Bell]]></category>
		<category><![CDATA[Thineskrishna Anbarasan]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/95bc8667a2094e3ca6785281c0f791c2.webp"/> <br/> <br/> Dimitrios Doultsinos, Principal Investigator in Prostate Cancer Research at University of Oxford, shared a post on LinkedIn: &#8220;Had the privilege of presenting my work at EACR2026 in Budapest yesterday! Huge [&#8230;]]]></description>
							</item>
		<item>
		<title>Mark Lawler: Strong Collaboration to Tackle Cancer Workforce, Inequality, and Innovation Gaps</title>
		<link>https://oncodaily.com/voices/mark-lawler518769</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/9259b2dc1c6d4652b06acdfc2acd4fb0.webp" />
		<pubDate>Thu, 11 Jun 2026 03:29:00 +0000</pubDate>
		<guid isPermaLink="false">74b750e77c49c6d3c45ec751ccca53b2</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer research]]></category>
		<category><![CDATA[Health in All Policies]]></category>
		<category><![CDATA[Mark Lawler]]></category>
		<category><![CDATA[National Cancer Control Programmes]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pat Price Radiotherapy UK]]></category>
		<category><![CDATA[The Economist World Cancer Series Europe]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/9259b2dc1c6d4652b06acdfc2acd4fb0.webp"/> <br/> <br/> Mark Lawler, Associate Director of Postgraduate Studies, Chair in Translational Cancer Genomics, and Professor of Digital Health at Queen’s University Belfast, shared a post on LinkedIn: &#8220;As we end two [&#8230;]]]></description>
							</item>
		<item>
		<title>Paz Vellanki: My First ASCO as Part of Precision for Medicine is in the Books!</title>
		<link>https://oncodaily.com/voices/paz-vellanki-518736</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/1781013161041.webp" />
		<pubDate>Thu, 11 Jun 2026 03:28:51 +0000</pubDate>
		<guid isPermaLink="false">fdc25c0788d46d8ac009625a959ddbd1</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[ASCO]]></category>
		<category><![CDATA[ASCO 2026]]></category>
		<category><![CDATA[ASCO26]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Paz Vellanki]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/1781013161041.webp"/> <br/> <br/> Paz Vellanki,Vice President Clinical Development, Oncology at Precision For Medicine, shared a post on LinkedIn: &#8220;My first ASCO as part of Precision For Medicine is in the books! It was [&#8230;]]]></description>
							</item>
		<item>
		<title>Apply Now and Don&#8217;t Miss Your Chance to Join Us at SZIGET 2026! &#8211; Youth Cancer Europe</title>
		<link>https://oncodaily.com/voices/youth-cancer-europe-518732</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2025/06/Youth_Cancer_Europe_Logo_-1-e1750146294955.png" />
		<pubDate>Thu, 11 Jun 2026 03:26:21 +0000</pubDate>
		<guid isPermaLink="false">6fb9bf4e45c11c711f322735af12aeca</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[SZIGET]]></category>
		<category><![CDATA[SZIGET 2026]]></category>
		<category><![CDATA[Youth Cancer Europe]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2025/06/Youth_Cancer_Europe_Logo_-1-e1750146294955.png"/> <br/> <br/> Youth Cancer Europe shared a post on LinkedIn: &#8220;Apply Now and don&#8217;t miss your chance to join us at SZIGET 2026! The only thing you need to bring is yourself [&#8230;]]]></description>
							</item>
		<item>
		<title>Cyril Sobolewski: Thanks Noemie Legrand and Noémie Gellée for Representing INFINITE at EACR2026</title>
		<link>https://oncodaily.com/voices/cyril-sobolewski-518718</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/06/e9851324f3004859b7b792813176c756.webp" />
		<pubDate>Thu, 11 Jun 2026 03:17:47 +0000</pubDate>
		<guid isPermaLink="false">4c29a7c2cec48282d3f608e5fb85a777</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cyril Sobolewski]]></category>
		<category><![CDATA[EACR]]></category>
		<category><![CDATA[EACR 2026]]></category>
		<category><![CDATA[EACR2026]]></category>
		<category><![CDATA[EACR26]]></category>
		<category><![CDATA[Noémie Gellée]]></category>
		<category><![CDATA[Noemie Legrand]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/06/e9851324f3004859b7b792813176c756.webp"/> <br/> <br/> Cyril Sobolewski, Professeur at University of Lille, shared a post on LinkedIn: &#8220;The European Association for Cancer Research meeting is ongoing in Budapest! Thanks Noemie Legrand and Noémie Gellée for representing [&#8230;]]]></description>
							</item>
	</channel>
</rss>
